Intriguingly, the improvements of OGTT, plasma insulin and HOMA-IR were observed in HFD-INU group (p < 0.001, Figures 2C–E), indicating that INU effectively attenuated insulin resistance in NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.